Hopefully ATomo can still replicate the current success of Ellume. "US grants $302 million contract to Brisbane bio-tech firm Ellume to produce at-home COVID tests". I think it should start here in Australia with government giving the chance for rapid testing. Currently Perth is in a lockdown and have seen people queued for more than 3 hours for the conventional testing. If thats the case i would be happy to jump back at AT1 to recoup my loss and eventually make profit. Same also for the longtime holders who believe in this company, a gain in the future.
AT1 Price at posting:
28.5¢ Sentiment: None Disclosure: Not Held
